NanoViricides (NYSE-A:NNVC) has been awarded a ‘Buy’ rating and $6.50 price target by analysts at EF Hutton following the release of positive data on the anti-influenza A/H3N2 activity of its therapy NV-387.
In a lethal animal model of lung infection, NV-387 treatment showed a longer survival lifespan of 15 days compared to eight to 11 days for three approved anti-influenza drugs, the analysts highlighted.
Analysts at UBS have lowered their price target on shipping and logistics company FedEx Corp (NYSE:FDX, ETR:FDX) ahead of its fiscal fourth quarter earnings report, pointing to multiple headwinds that will dampen the impact of its cost-cutting program in fiscal 2025.
The analysts reduced their price target to $333 to $340 on lower earnings per share (EPS) estimates but awarded the stock a ‘Buy’ rating.
Schroders PLC (LSE:SDR) was one of the top risers on the FTSE 100 on Tuesday, helped by a UBS upgrade after the shares have underperformed so far this year.
The stock has fallen 9% in the year to date, the Swiss bank noted, underperforming the STOXX 600 by 16% and the listed EU asset managers by 11%.
A diversification away from Wise PLC (LSE:WISE)’s core foreign exchange offerings will “drive the next leg of growth”, Barclays analysts said in a Tuesday research note.
Analysts upgraded the London-listed financial technology group, noting this diversification strategy “offers sufficient levers to continue growth” of more than 20% in the mid-term at a roughly 25% margin.
South West Water owner Pennon Group PLC (LSE:PNN, OTC:PEGRY) offered “no positives” in its annual earning statement today, said analysts at UBS.
Underlying earnings came below UBS estimates of £171 million and the company-compiled consensus of £174 million.
After AstraZeneca PLC (LSE:AZN) unveiled new sales and profit targets for the end of the decade, analysts were mildly impressed by the ambition to "shoot for the stars".
Starting with the bare numbers, UBS noted that the new target to achieve $80 billion in total revenue by 2030 compared to consensus core revenue of $67 billion and its own forecast of $72 billion.
A £2.2 billion by private equity bid for Keywords Studios PLC (AIM:KWS, OTC:KYYWF) would unwind the damage done to the stock over the past year by the apparent (rather than real) threat posed by artificial intelligence, according to American bank Citi.
Over the past year, investors have been fretting that Keywords' position as a provider of support services to the video games industry will be undermined by automation. Shares slid more than 60%.
Shares in Creo Medical Group PLC (AIM:CREO), a company specialising in surgical endoscopy and advanced energy licensing, are rated by Deutsche Bank as 'buy' up to 80p.
In a short update in the wake of full-year results, the German outfit flagged as its key highlight the approval and launch of the Speedboat UltraSlim, which improves compatibility with a broader range of endoscopes. This development is expected to enhance the company's market position and drive future growth.
GSK PLC (LSE:GSK, NYSE:GSK) may face a settlement of up to $2 billion to resolve thousands of lawsuits related to Zantac, a heartburn medication linked to cancer, according to an estimate from the investment banking arm of Barclays.
Zantac was pulled from the market in 2019 after the US Food and Drug Administration (FDA) found it contained N-nitrosodimethylamine (NDMA), a probable carcinogen. This discovery led to numerous lawsuits from patients who alleged that they developed cancer after using the drug.
Union Jack Oil Plc's (AIM:UJO, OTCQB:UJOGF) decision not to release production numbers for its last year makes it difficult to assess why revenues fell, but lower commodity prices will have been a major factor says, Panmure Gordon.
Reserves were increased at Wressle with further development planned.
A second City investment bank has said now is the time to buy UK shares as pension funds have “nothing left to sell”.
According to analysts at HSBC: “The long-term structural overhang of UK pension fund selling is at an end” and now represents a “golden opportunity” to buy.